Arkolith/Insider Trading/IDXG/Form 4

McCarthy Christopher

Chief Financial OfficerINTERPACE BIOSCIENCES, INC. (IDXG) · full profile →Form 4 · filed Apr 25, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2024Option exercise(M)1K—$047K
Jul 27, 2024Option exercise(M)15K—$046K
Feb 1, 2024Option exercise(M)6K—$031K
Jan 31, 2024Option exercise(M)8K—$025K
Dec 1, 2023Option exercise(M)1K—$017K
Jul 31, 2023Option exercise(M)8K—$016K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-006211) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML